XML 19 R42.htm IDEA: XBRL DOCUMENT
v3.20.1

SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables) | 12 Months Ended
--- | ---
Mar. 28, 2020
Segment Reporting [Abstract] |
Selected Information by Business Segment |
(In thousands) | 2020 |  | 2019 |  | 2018
Net revenues |  |  |  |  |
Plasma | $ | 460,637 |  |  | $ | 426,781 |  |  | $ | 363,254 |
Blood Center | 325,661 |  |  | 335,557 |  |  | 347,373 |
Hospital | 194,604 |  |  | 190,821 |  |  | 178,116 |
Net revenues by business unit | 980,902 |  |  | 953,159 |  |  | 888,743 |
Service (1) | 19,830 |  |  | 19,906 |  |  | 20,574 |
Effect of exchange rates | (12,253 | ) |  | (5,486 | ) |  | (5,394 | )
Net revenues | $ | 988,479 |  |  | $ | 967,579 |  |  | $ | 903,923 |
(1) Reflects revenue for service, maintenance and parts. |  |  |  |  |
(In thousands) | 2020 |  | 2019 |  | 2018
Segment operating income |  |  |  |  |
Plasma | $ | 225,351 |  |  | $ | 180,300 |  |  | $ | 146,986 |
Blood Center | 159,802 |  |  | 163,628 |  |  | 170,172 |
Hospital | 80,669 |  |  | 76,338 |  |  | 67,258 |
Segment operating income | 465,822 |  |  | 420,266 |  |  | 384,416 |
Corporate expenses (1) | (255,727 | ) |  | (263,603 | ) |  | (257,229 | )
Effect of exchange rates | 7,920 |  |  | 8,367 |  |  | 4,060 |
Impairment of assets and other related charges (2) | (51,220 | ) |  | (21,170 | ) |  | (1,941 | )
Deal amortization | (25,746 | ) |  | (24,803 | ) |  | (26,013 | )
PCS2 accelerated depreciation and related costs | (24,530 | ) |  | (19,126 | ) |  | — |
Restructuring and turnaround costs | (19,878 | ) |  | (13,660 | ) |  | (44,125 | )
European Medical Device Regulation costs | (1,506 | ) |  | — |  |  | — |
Other (3) | 133 |  |  | (2,726 | ) |  | (3,011 | )
Gain on sale of assets (4) | 8,083 |  |  | — |  |  | — |
Operating income | $ | 103,351 |  |  | $ | 83,545 |  |  | $ | 56,157 |
(1) Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions. (2) Includes a $1.9 million adjustment to fiscal 2020 Plasma revenue due to an accelerated charge incurred as a result of the divestiture of the Union, South Carolina liquid solutions operation. (3) Includes transaction costs and costs related to the resolution of customer damages associated with product recalls. (4) Reflects gain on the sale of the Company's Braintree corporate headquarters.
(In thousands) | 2020 |  | 2019 |  | 2018
Depreciation and amortization |  |  |  |  |
Plasma | $ | 38,429 |  |  | $ | 38,074 |  |  | $ | 47,985 |
Blood Center | 8,513 |  |  | 9,623 |  |  | 11,439 |
Hospital | 63,347 |  |  | 61,721 |  |  | 29,823 |
Total depreciation and amortization (excluding impairment charges) | $ | 110,289 |  |  | $ | 109,418 |  |  | $ | 89,247 |
(In thousands) | March 28, 2020 |  | March 30, 2019 |  | March 31, 2018
Long-lived assets(1) |  |  |  |  |
Plasma | $ | 141,903 |  |  | $ | 192,628 |  |  | $ | 186,007 |
Blood Center | 93,758 |  |  | 127,272 |  |  | 122,898 |
Hospital | 17,738 |  |  | 24,079 |  |  | 23,251 |
Total long-lived assets | $ | 253,399 |  |  | $ | 343,979 |  |  | $ | 332,156 |
(1) Long-lived assets are comprised of property, plant and equipment.
Selected information by principle operating regions is presented below:
(In thousands) | March 28, 2020 |  | March 30, 2019 |  | March 31, 2018
Long-lived assets(1) |  |  |  |  |
United States | $ | 186,488 |  |  | $ | 269,849 |  |  | $ | 236,603 |
Japan | 2,037 |  |  | 1,726 |  |  | 1,511 |
Europe | 10,143 |  |  | 11,200 |  |  | 13,696 |
Asia | 29,175 |  |  | 30,930 |  |  | 36,431 |
Other | 25,556 |  |  | 30,274 |  |  | 43,915 |
Total long-lived assets | $ | 253,399 |  |  | $ | 343,979 |  |  | $ | 332,156 |
(1) Long-lived assets are comprised of property, plant and equipment.
(In thousands) | 2020 |  | 2019 |  | 2018
United States | $ | 646,204 |  |  | $ | 606,845 |  |  | $ | 548,731 |
Japan | 72,218 |  |  | 69,908 |  |  | 67,319 |
Europe | 153,347 |  |  | 164,504 |  |  | 164,226 |
Asia | 109,295 |  |  | 118,700 |  |  | 115,127 |
Other | 7,415 |  |  | 7,622 |  |  | 8,520 |
Net revenues | $ | 988,479 |  |  | $ | 967,579 |  |  | $ | 903,923 |
Schedule of Revenues by Product Line | et revenues by product line are as follows:
(In thousands) | 2020 |  | 2019 |  | 2018
Plasma products and services | 537,231 |  |  | 501,837 |  |  | 435,956 |
Blood Center products and services | 252,829 |  |  | 269,203 |  |  | 284,902 |
Hospital products and services | 198,419 |  |  | 196,539 |  |  | 183,065 |
Net revenues | $ | 988,479 |  |  | $ | 967,579 |  |  | $ | 903,923 |

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 + Details
Name: | us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration